IMMUCELL CORP's ticker is ICCC and the CUSIP is 452525306. A total of 28 filers reported holding IMMUCELL CORP in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $812 | +6.8% | 152 | 0.0% | 0.00% | – |
| Q2 2023 | $760 | -2.2% | 152 | 0.0% | 0.00% | – |
| Q1 2023 | $777 | -16.2% | 152 | 0.0% | 0.00% | – |
| Q4 2022 | $927 | -7.3% | 152 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 152 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 152 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 152 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 152 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 152 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 152 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 152 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 152 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 152 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 152 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 152 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 152 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 152 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 152 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | – | 152 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Financial Services, Inc. | 23,776 | $89,000 | 0.03% |
| SHUFRO ROSE & CO LLC | 51,263 | $192,000 | 0.02% |
| Tower Research Capital LLC (TRC) | 254 | $1,000 | 0.00% |
| Creative Planning | 310 | $1,000 | 0.00% |
| Renaissance Technologies | 10,000 | $38,000 | 0.00% |
| UBS AG | 1,870 | $7,000 | 0.00% |
| US BANCORP \DE\ | 24 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 2,032 | $8,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1 | $0 | 0.00% |
| MORGAN STANLEY | 29,628 | $111,000 | 0.00% |